In our clinical trial, we examined the effects of a probiotic combination of Lactobacillus acidophilus and L. plantarum on patients with diarrhea-predominant irritable bowel syndrome (IBS-D). We randomly assigned 100 participants to standard IBS treatment or the same treatment plus probiotics over 12 weeks.
Both groups experienced significant symptom relief, but those taking probiotics saw even greater improvements. By the end of the study, everyone in the probiotic group achieved either complete remission or mild symptoms, while some in the standard treatment group still reported moderate issues. These results suggest that adding probiotics could enhance IBS management strategies.
Read More
Effective probiotic IBS treatmentTwo Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
High relevance for IBS management
This randomized, single-blinded trial evaluated the impact of probiotics, specifically Lactobacillus acidophilus and plantarum, on patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
We found that when added to standard IBS treatment, these probiotics significantly improved symptoms over a 12-week period.
Group B, the probiotic group, experienced better results, including fewer days with pain and greater satisfaction with bowel habits. While both groups saw reductions in IBS severity, the probiotics led to complete remission in many patients, which is promising for future treatment guidelines.
Read More
Effective probiotic IBS treatmentTwo Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
High relevance for IBS management
This randomized, single-blinded trial evaluated the impact of probiotics, specifically Lactobacillus acidophilus and plantarum, on patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
We found that when added to standard IBS treatment, these probiotics significantly improved symptoms over a 12-week period.
Group B, the probiotic group, experienced better results, including fewer days with pain and greater satisfaction with bowel habits. While both groups saw reductions in IBS severity, the probiotics led to complete remission in many patients, which is promising for future treatment guidelines.
Read More
Probiotic milk improves IBS symptomsClinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink.
Relevant for constipation symptom management
We examined the effects of a daily cultured milk drink containing Lactobacillus acidophilus on individuals with constipation-predominant irritable bowel syndrome (IBS-C). Over 30 days, participants reported significant relief in constipation symptoms alongside improved intestinal transit time and decreased fecal pH.
Notably, the pro-inflammatory cytokines levels also dropped significantly, indicating a positive immune response. These results suggest that incorporating probiotic-rich cultured milk drinks might serve as a helpful addition to treat this condition effectively.
Read More
Probiotics relieve IBS symptoms DDS-1 and UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.
Highly relevant clinical insights
We investigated the effects of two probiotic strains, DDS-1 and UABla-12, on abdominal pain and symptoms in people with irritable bowel syndrome (IBS). In a well-structured study involving 330 participants, those receiving probiotics experienced significant improvements in pain severity compared to a placebo group.
The DDS-1 strain showed a 52.3% response rate, while UABla-12 had a 28.2% response. Both probiotics also improved overall IBS symptoms, bowel consistency, and quality of life measures.
These findings suggest that probiotics could be a beneficial option for managing IBS symptoms.
Read More